Roberto Pineda-Reyes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Roberto Pineda-Reyes has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Miguel Mauricio Cabada
Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA
4 shared publications - David Reynoso
Infectious Disease Division, University of Texas Medical Branch , Galveston, Texas
3 shared publications - Eloy Francisco Ruiz
Geriatric Evidence & Research Initiative (GERI‐AMAUTA), Section of Geriatric Medicine, Department of Medicine Rutgers New Jersey Medical School Newark New Jersey USA
2 shared publications - George Vasquez-Rios
Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO, United States of America
2 shared publications - Jakob Zinsstag
Swiss Tropical and Public Health Institute, University of Basel, Kreuzstrasse 2, 4123 Allschwil, Switzerland, Switzerland
2 shared publications Joseph Orndorff
Department of Internal Medicine, University of Texas Medical Branch , Galveston, Texas
2 shared publications
Latest Publications
- 2 September 2026
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 115 (3) , 563-570
Frequency, Geospatial Distribution, and Subspecies of Echinococcus granulosus Identified in Dog Stool in Urban Public Spaces of an Endemic Area in Cusco, Peru
: The impact of environmental contamination with Echinococcus granulosus eggs on the transmission to humans remains unknown. The control of free-roaming and stray dogs is a public health problem in urban and periurban areas of the Cusco region, such as the city of Sicuani in the Canchis province. Nearly one in four human cystic echinococcosis cases referred to tertiary hospitals in the Cusco region of Peru is referred from the Sicuani district. This study sought to determine the frequency and spatial distribution of E. granulosus DNA in dog stool collected within urban public spaces of Sicuani. We conducted a cross-sectional study using a systematic 100 × 100-meters 2 grid-based sampling design. Dog stools located at the closest point to georeferenced square vertices were selected for collection. Epidemiologically relevant locations, such as abattoirs and food markets, were also georeferenced. Nineteen (5.5%) of 347 collected samples tested positive for E. granulosus DNA. Polymerase chain reaction (PCR)-positive stools were located at a shorter median distance than negative stools to abattoirs (564 versus 1,292 meters, respectively, P E. granulosus sensu stricto (G1) with close phylogenetic relationship. Our field study revealed that E. granulosus PCR-positive dog stools were associated with spatial proximity to abattoirs. Interventions to decrease E. granulosus infections among dogs, particularly around abattoirs, may decrease the potential environmental contamination with infective stages.
- 2 September 2026
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 115 (3) , 563-570
Frequency, Geospatial Distribution, and Subspecies of Echinococcus granulosus Identified in Dog Stool in Urban Public Spaces of an Endemic Area in Cusco, Peru
: The impact of environmental contamination with Echinococcus granulosus eggs on the transmission to humans remains unknown. The control of free-roaming and stray dogs is a public health problem in urban and periurban areas of the Cusco region, such as the city of Sicuani in the Canchis province. Nearly one in four human cystic echinococcosis cases referred to tertiary hospitals in the Cusco region of Peru is referred from the Sicuani district. This study sought to determine the frequency and spatial distribution of E. granulosus DNA in dog stool collected within urban public spaces of Sicuani. We conducted a cross-sectional study using a systematic 100 × 100-meters 2 grid-based sampling design. Dog stools located at the closest point to georeferenced square vertices were selected for collection. Epidemiologically relevant locations, such as abattoirs and food markets, were also georeferenced. Nineteen (5.5%) of 347 collected samples tested positive for E. granulosus DNA. Polymerase chain reaction (PCR)-positive stools were located at a shorter median distance than negative stools to abattoirs (564 versus 1,292 meters, respectively, P E. granulosus sensu stricto (G1) with close phylogenetic relationship. Our field study revealed that E. granulosus PCR-positive dog stools were associated with spatial proximity to abattoirs. Interventions to decrease E. granulosus infections among dogs, particularly around abattoirs, may decrease the potential environmental contamination with infective stages.
- Open Access
Clinical management, epidemiology, and recurrence of human cystic echinococcosis in a secondary care level hospital in an endemic area of the Andes in Sicuani, Cusco, Peru
Peru has the highest incidence of human cystic echinococcosis (CE) in South America and most cases are reported in the Central and Southern Peruvian Andes, including the Cusco region. We reviewed medical records of patients with CE admitted between 2010-2019 to a level-2 hospital in Sicuani, which serves the Canchis province of Cusco. We collected data on surgical management and disease recurrence. Records from 115 patients were included, their median age was 25 years (IQR, 16-46) and 60% were female. Most patients (68.7%) presented with a single liver cyst. The Gharbi classification was used in 75/107 (70.1%) patients with an ultrasound and in 91/142 cysts (64.8%). Thirty-one (34.1%) were classified as Gharbi I, 33 (36.3%) Gharbi II, 21 (23.1%) Gharbi III, and 6 (6.6%) Gharbi IV. Pre-surgical complications were reported in 41.7%. One hundred two patients underwent surgery. In 39.2% a secondary CE prevention measure was documented, 5.9% had two, and one had the three recommended measures. Post-surgical cyst recurrence was reported in 16.5% at a median 32.3 months (IQR, 3.9-46.6) and readmissions in 12.7%. In the multivariable analysis, having ≥3 cysts (OR 6.26, 95% CI 1.10-39.85) was associated with post-surgical cyst recurrence. Advanced and complicated CE and post-surgical recurrence were common in Sicuani. Standardization of ultrasound staging-guided clinical management along with secondary CE prevention measures could effectively decrease the disease burden linked to clinical care, improving outcomes and decreasing costs. Ultimately, only integrated control at the source of infection including hand hygiene, secure disposal of offal, avoidance of dog feeding offal, and deworming of dogs can reduce transmission and lead to elimination.
Open AccessClinical management, epidemiology, and recurrence of human cystic echinococcosis in a secondary care level hospital in an endemic area of the Andes in Sicuani, Cusco, Peru
Peru has the highest incidence of human cystic echinococcosis (CE) in South America and most cases are reported in the Central and Southern Peruvian Andes, including the Cusco region. We reviewed medical records of patients with CE admitted between 2010-2019 to a level-2 hospital in Sicuani, which serves the Canchis province of Cusco. We collected data on surgical management and disease recurrence. Records from 115 patients were included, their median age was 25 years (IQR, 16-46) and 60% were female. Most patients (68.7%) presented with a single liver cyst. The Gharbi classification was used in 75/107 (70.1%) patients with an ultrasound and in 91/142 cysts (64.8%). Thirty-one (34.1%) were classified as Gharbi I, 33 (36.3%) Gharbi II, 21 (23.1%) Gharbi III, and 6 (6.6%) Gharbi IV. Pre-surgical complications were reported in 41.7%. One hundred two patients underwent surgery. In 39.2% a secondary CE prevention measure was documented, 5.9% had two, and one had the three recommended measures. Post-surgical cyst recurrence was reported in 16.5% at a median 32.3 months (IQR, 3.9-46.6) and readmissions in 12.7%. In the multivariable analysis, having ≥3 cysts (OR 6.26, 95% CI 1.10-39.85) was associated with post-surgical cyst recurrence. Advanced and complicated CE and post-surgical recurrence were common in Sicuani. Standardization of ultrasound staging-guided clinical management along with secondary CE prevention measures could effectively decrease the disease burden linked to clinical care, improving outcomes and decreasing costs. Ultimately, only integrated control at the source of infection including hand hygiene, secure disposal of offal, avoidance of dog feeding offal, and deworming of dogs can reduce transmission and lead to elimination.
- 17 May 2024
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 79 (5) , 1144-1152
Clinical Presentation, Antimicrobial Resistance, and Treatment Outcomes of Aeromonas Human Infections: A 14-Year Retrospective Study and Comparative Genomics of 2 Isolates From Fatal Cases
Aeromonas virulence may not be entirely dependent on the host immune status. Pathophysiologic determinants of disease progression and severity remain unclear. One hundred five patients with Aeromonas infections and 112 isolates were identified, their clinical presentations and outcomes analyzed, and their antimicrobial resistance (AMR) patterns assessed. Two isolates (A and B) from fatal cases of Aeromonas dhakensis bacteremia were characterized using whole genome sequence analysis. Virulence factor- and AMR-encoding genes from these isolates were compared with a well-characterized diarrheal isolate A. dhakensis SSU, and environmental isolate A. hydrophila ATCC_7966T. Skin and soft tissue infections, traumatic wound infections, sepsis, burns, and intraabdominal infections were common. Diabetes, malignancy, and cirrhosis were frequent comorbidities. Male sex, age ≥ 65 years, hospitalization, burns, and intensive care were associated with complicated disease. High rates of AMR to carbapenems and piperacillin-tazobactam were found. Treatment failure was observed in 25.7% of cases. Septic shock and hospital-acquired infections were predictors of treatment failure. All four isolates harbored assorted broad-spectrum AMR genes including blaOXA, ampC, cphA, and efflux pumps. Only clinical isolates possessed both polar and lateral flagellar genes, genes for various surface adhesion proteins, type 3- and -6 secretion systems and their effectors, and toxin genes, including exotoxin A. Both isolates A and B were resistant to colistin and harbored the mobile colistin resistance-3 (mcr-3) gene. Empirical therapy tailored to local Aeromonas antibiograms may facilitate more favorable outcomes, while advanced diagnostic methods may aid in identifying correct Aeromonas spp. of significant clinical importance.
- 17 May 2024
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 79 (5) , 1144-1152
Clinical Presentation, Antimicrobial Resistance, and Treatment Outcomes of Aeromonas Human Infections: A 14-Year Retrospective Study and Comparative Genomics of 2 Isolates From Fatal Cases
Aeromonas virulence may not be entirely dependent on the host immune status. Pathophysiologic determinants of disease progression and severity remain unclear. One hundred five patients with Aeromonas infections and 112 isolates were identified, their clinical presentations and outcomes analyzed, and their antimicrobial resistance (AMR) patterns assessed. Two isolates (A and B) from fatal cases of Aeromonas dhakensis bacteremia were characterized using whole genome sequence analysis. Virulence factor- and AMR-encoding genes from these isolates were compared with a well-characterized diarrheal isolate A. dhakensis SSU, and environmental isolate A. hydrophila ATCC_7966T. Skin and soft tissue infections, traumatic wound infections, sepsis, burns, and intraabdominal infections were common. Diabetes, malignancy, and cirrhosis were frequent comorbidities. Male sex, age ≥ 65 years, hospitalization, burns, and intensive care were associated with complicated disease. High rates of AMR to carbapenems and piperacillin-tazobactam were found. Treatment failure was observed in 25.7% of cases. Septic shock and hospital-acquired infections were predictors of treatment failure. All four isolates harbored assorted broad-spectrum AMR genes including blaOXA, ampC, cphA, and efflux pumps. Only clinical isolates possessed both polar and lateral flagellar genes, genes for various surface adhesion proteins, type 3- and -6 secretion systems and their effectors, and toxin genes, including exotoxin A. Both isolates A and B were resistant to colistin and harbored the mobile colistin resistance-3 (mcr-3) gene. Empirical therapy tailored to local Aeromonas antibiograms may facilitate more favorable outcomes, while advanced diagnostic methods may aid in identifying correct Aeromonas spp. of significant clinical importance.
- Open Access
- 1 December 2022
- Published by American College of Physicians in Annals of Internal Medicine: Clinical Cases
- Vol. 1 (10)
Nyctalopia and Bitot Spots
Vitamin A deficiency is endemic in resource-poor areas of low- and middle-income countries in Latin America, sub-Saharan Africa, and South Asia. Although rare in the United States, individuals at r...
- 1 December 2022
- Published by American College of Physicians in Annals of Internal Medicine: Clinical Cases
- Vol. 1 (10)
Open AccessNyctalopia and Bitot Spots
Vitamin A deficiency is endemic in resource-poor areas of low- and middle-income countries in Latin America, sub-Saharan Africa, and South Asia. Although rare in the United States, individuals at r...
- Open Access
- 20 July 2022
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 44 (7) , 1184-1186
Single-center investigation on central-line–associated bloodstream infections and blood-culture contamination during the early months of the coronavirus disease 2019 (COVID-19) pandemic
In this retrospective cohort study, we assessed central-line–associated bloodstream infections (CLABSIs) and blood-culture contamination frequency during the first pandemic wave. Coronavirus disease 2019 (COVID-19) was significantly associated with CLABSI and blood-culture contamination. In the COVID-19 cohort, malignancy was associated with CLABSI. Black race, end-stage renal disease, and obesity were associated with blood-culture contamination.
- 20 July 2022
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 44 (7) , 1184-1186
Open AccessSingle-center investigation on central-line–associated bloodstream infections and blood-culture contamination during the early months of the coronavirus disease 2019 (COVID-19) pandemic
In this retrospective cohort study, we assessed central-line–associated bloodstream infections (CLABSIs) and blood-culture contamination frequency during the first pandemic wave. Coronavirus disease 2019 (COVID-19) was significantly associated with CLABSI and blood-culture contamination. In the COVID-19 cohort, malignancy was associated with CLABSI. Black race, end-stage renal disease, and obesity were associated with blood-culture contamination.
- Open Access
- 4 December 2021
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 8 (Supplement) , S723
1269. Infection, Clinical Syndromes and Antimicrobial Resistance by Aeromonas species: 13-Year Experience with an Emerging Pathogen at a Tertiary Care Center
Aeromonas spp. are emerging pathogens that cause a wide breadth of clinical syndromes, ranging from acute gastroenteritis to skin and soft tissue infections, sepsis, and “flesh-eating” necrotizing fasciitis. Aeromonads have been associated with natural disasters and have predominance in estuarine ecosystems, generating a negative impact on the fishing industry and aquaculture, as well as morbidity and mortality in human populations at risk. Antimicrobial resistance patterns differ by geographic locations worldwide, and studies to guide the therapy in the era of multidrug resistance are lacking in the US. A retrospective case series was designed to chart review all adult subjects who had culture proven Aeromonas spp. infections during the period 2008-2020. Demographic data, water exposure, clinical syndromes on presentation, origin (community-acquired vs. nosocomial) and severity of infection, antibiograms, empirical antibiotics, time-to-appropriate therapy, and treatment outcomes were collected. Eighty-two subjects were included in the analysis. Demographic and clinical data is summarized in Table 1. Near 20% individuals had water exposure, including 53% of those with traumatic wound infections. Skin and soft tissue infection (including traumatic and surgical wound infections) was the most frequent clinical syndrome (51.2%). Sepsis was present on admission in 33% inpatients. Appropriate antibiotics were instituted in a median of 2 days (IQR=1-5), and the most prescribed empiric agents were piperacillin-tazobactam (48%) and meropenem (13.3%). Most isolates were susceptible to cefepime (70/71, 98.6%), levofloxacin (72/78, 92.3%) and TMP-SMX (69/78, 88.5%). Resistance to meropenem was reported in 18/31 isolates (58.1%) after 2015. Treatment failure was identified in 32.3% cases. Most cases (55%) were encountered during the months of spring and summer, which have warmer temperatures and seasonal heavy rains. Tropical storms caused significant flooding in the Galveston Bay area and Southeast Texas during the summer of 2015, which interestingly coincides with the high number of cases. However, following Hurricane Ike in 2008 or Hurricane Harvey in 2017, the number of cases did not significantly increase. Aeromonads are emerging pathogens that cause mainly intraabdominal and skin and soft tissue infections. Their incidence is seasonal (55% cases in spring and summer) and it is associated with water exposure in more than half of those with traumatic wound infections. In subjects with specific risk factors, the use of carbapenem-sparing strategies, such as 3rd or 4th generation cephalosporins, fluoroquinolones or TMP-SMX, may improve outcomes. All Authors: No reported disclosures
- 4 December 2021
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 8 (Supplement) , S723
Open Access1269. Infection, Clinical Syndromes and Antimicrobial Resistance by Aeromonas species: 13-Year Experience with an Emerging Pathogen at a Tertiary Care Center
Aeromonas spp. are emerging pathogens that cause a wide breadth of clinical syndromes, ranging from acute gastroenteritis to skin and soft tissue infections, sepsis, and “flesh-eating” necrotizing fasciitis. Aeromonads have been associated with natural disasters and have predominance in estuarine ecosystems, generating a negative impact on the fishing industry and aquaculture, as well as morbidity and mortality in human populations at risk. Antimicrobial resistance patterns differ by geographic locations worldwide, and studies to guide the therapy in the era of multidrug resistance are lacking in the US. A retrospective case series was designed to chart review all adult subjects who had culture proven Aeromonas spp. infections during the period 2008-2020. Demographic data, water exposure, clinical syndromes on presentation, origin (community-acquired vs. nosocomial) and severity of infection, antibiograms, empirical antibiotics, time-to-appropriate therapy, and treatment outcomes were collected. Eighty-two subjects were included in the analysis. Demographic and clinical data is summarized in Table 1. Near 20% individuals had water exposure, including 53% of those with traumatic wound infections. Skin and soft tissue infection (including traumatic and surgical wound infections) was the most frequent clinical syndrome (51.2%). Sepsis was present on admission in 33% inpatients. Appropriate antibiotics were instituted in a median of 2 days (IQR=1-5), and the most prescribed empiric agents were piperacillin-tazobactam (48%) and meropenem (13.3%). Most isolates were susceptible to cefepime (70/71, 98.6%), levofloxacin (72/78, 92.3%) and TMP-SMX (69/78, 88.5%). Resistance to meropenem was reported in 18/31 isolates (58.1%) after 2015. Treatment failure was identified in 32.3% cases. Most cases (55%) were encountered during the months of spring and summer, which have warmer temperatures and seasonal heavy rains. Tropical storms caused significant flooding in the Galveston Bay area and Southeast Texas during the summer of 2015, which interestingly coincides with the high number of cases. However, following Hurricane Ike in 2008 or Hurricane Harvey in 2017, the number of cases did not significantly increase. Aeromonads are emerging pathogens that cause mainly intraabdominal and skin and soft tissue infections. Their incidence is seasonal (55% cases in spring and summer) and it is associated with water exposure in more than half of those with traumatic wound infections. In subjects with specific risk factors, the use of carbapenem-sparing strategies, such as 3rd or 4th generation cephalosporins, fluoroquinolones or TMP-SMX, may improve outcomes. All Authors: No reported disclosures
- 1 September 2020
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 37, 101859
Incidence of acute mountain sickness and healthcare related behaviors among travelers to Cusco, Peru
- 1 September 2020
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 37, 101859
Incidence of acute mountain sickness and healthcare related behaviors among travelers to Cusco, Peru
- Open Access
- 3 December 2019
- Published by Hindawi Limited in Case Reports in Infectious Diseases
- Vol. 2019, 1-4
Early Diagnosis of Latent Tuberculosis Reactivation due to Drug Interaction between Cobicistat and Intranasal Fluticasone
Background. Single-tablet antiretroviral therapy is currently the first-line choice for the treatment of HIV infection. Some therapeutic regimens contain the CYP3A4 inhibitor cobicistat, which can interact with drugs undergoing hepatic first-pass metabolism, leading to unintended adverse effects. Case Presentation. A 41-year-old man presented to the HIV clinic following a visit to the Emergency Department. His CD4+ count was 1,271 cells/μL, and viral load was undetectable in the previous month. The patient was on an antiretroviral therapy regimen containing cobicistat. He reported using a self-initiated over-the-counter fluticasone nasal spray for at least 2 weeks prior. He had a history of positive tuberculin skin test and a negative chest X-ray within the past year. He denied cough and was in no respiratory distress. A chest CT scan revealed a new thick-walled cavitary nodule in the right upper lobe. A CT-guided biopsy of the lesion yielded Mycobacterium tuberculosis. Conclusions. HIV-infected individuals have higher risk for tuberculosis reactivation regardless of their CD4+ count. Fluticasone’s hepatic metabolism is bypassed in the presence of CYP3A4 inhibitors, which increases its systemic bioavailability and the risk for impaired immunity. The goal of this report is to increase awareness among physicians about the potential adverse outcomes from the interaction of these drugs.
- 3 December 2019
- Published by Hindawi Limited in Case Reports in Infectious Diseases
- Vol. 2019, 1-4
Open AccessEarly Diagnosis of Latent Tuberculosis Reactivation due to Drug Interaction between Cobicistat and Intranasal Fluticasone
Background. Single-tablet antiretroviral therapy is currently the first-line choice for the treatment of HIV infection. Some therapeutic regimens contain the CYP3A4 inhibitor cobicistat, which can interact with drugs undergoing hepatic first-pass metabolism, leading to unintended adverse effects. Case Presentation. A 41-year-old man presented to the HIV clinic following a visit to the Emergency Department. His CD4+ count was 1,271 cells/μL, and viral load was undetectable in the previous month. The patient was on an antiretroviral therapy regimen containing cobicistat. He reported using a self-initiated over-the-counter fluticasone nasal spray for at least 2 weeks prior. He had a history of positive tuberculin skin test and a negative chest X-ray within the past year. He denied cough and was in no respiratory distress. A chest CT scan revealed a new thick-walled cavitary nodule in the right upper lobe. A CT-guided biopsy of the lesion yielded Mycobacterium tuberculosis. Conclusions. HIV-infected individuals have higher risk for tuberculosis reactivation regardless of their CD4+ count. Fluticasone’s hepatic metabolism is bypassed in the presence of CYP3A4 inhibitors, which increases its systemic bioavailability and the risk for impaired immunity. The goal of this report is to increase awareness among physicians about the potential adverse outcomes from the interaction of these drugs.
- Open Access
- 29 April 2019
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 13 (1) , 121
Strongyloides stercoralis infection after the use of emergency corticosteroids: a case report on hyperinfection syndrome
In clinical practice, identification of a case of severe asthma exacerbation prompts initiation of corticosteroids. However, not all that wheezes is asthma. A 61-year-old man from the Peruvian Amazon presented with progressive dyspnea, abdominal pain, and cough for the past week. His medical history was remarkable for asthma since childhood; he was treated with beta-agonists, ipratropium, and orally administered corticosteroids. On evaluation, he was febrile and ill-appearing. His chest examination revealed diffuse wheezing and bilateral crackles. He was diagnosed as having community-acquired pneumonia and asthma exacerbation and was started on empiric antibiotics, nebulized beta-agonists, and orally administered corticosteroids. His clinical status continued deteriorating and he became critically ill despite broad-spectrum antibiotics and antifungals. Considering the epidemiological background of our patient, bronchoalveolar and fecal samples were obtained to investigate soil-transmitted helminths. Larvae of Strongyloides stercoralis were found in both specimens. Ivermectin was initiated and corticosteroids were discontinued. He experienced remarkable improvement of clinical condition over the next weeks. The literature on this topic was reviewed. Cases of severe asthma exacerbation warrant careful evaluation before the initiation of corticosteroids, especially in patients at risk for parasitic infections. A high index of suspicion is critical. Alternative etiologies of respiratory decompensation should be considered in patients who fail to improve with broad-spectrum antibiotics and antifungals.
- 29 April 2019
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 13 (1) , 121
Open AccessStrongyloides stercoralis infection after the use of emergency corticosteroids: a case report on hyperinfection syndrome
In clinical practice, identification of a case of severe asthma exacerbation prompts initiation of corticosteroids. However, not all that wheezes is asthma. A 61-year-old man from the Peruvian Amazon presented with progressive dyspnea, abdominal pain, and cough for the past week. His medical history was remarkable for asthma since childhood; he was treated with beta-agonists, ipratropium, and orally administered corticosteroids. On evaluation, he was febrile and ill-appearing. His chest examination revealed diffuse wheezing and bilateral crackles. He was diagnosed as having community-acquired pneumonia and asthma exacerbation and was started on empiric antibiotics, nebulized beta-agonists, and orally administered corticosteroids. His clinical status continued deteriorating and he became critically ill despite broad-spectrum antibiotics and antifungals. Considering the epidemiological background of our patient, bronchoalveolar and fecal samples were obtained to investigate soil-transmitted helminths. Larvae of Strongyloides stercoralis were found in both specimens. Ivermectin was initiated and corticosteroids were discontinued. He experienced remarkable improvement of clinical condition over the next weeks. The literature on this topic was reviewed. Cases of severe asthma exacerbation warrant careful evaluation before the initiation of corticosteroids, especially in patients at risk for parasitic infections. A high index of suspicion is critical. Alternative etiologies of respiratory decompensation should be considered in patients who fail to improve with broad-spectrum antibiotics and antifungals.
- 6 February 2019
- Published by Springer Nature in Journal of Parasitic Diseases
- Vol. 43 (2) , 167-175
Strongyloides stercoralis hyperinfection syndrome: a deeper understanding of a neglected disease
Strongyloides stercoralis hyperinfection syndrome (SHS) is a life-threatening condition that warrants early detection and management. We describe the pathogenesis, organ-specific clinical manifestations, and risk factors associated to this condition. A comprehensive review of the literature was conducted in PubMed, LILACS, EBSCO and SciELO by using the keywords: “hyperinfection syndrome”; “Strongyloides stercoralis”; “disseminated strongyloidiasis”; “systemic strongyloidiasis”, “pathogenesis” and “pathophysiology”. Relevant articles on this topic were evaluated and included by consensus. Also, a secondary search of the literature was performed. Articles in English and Spanish language were included. SHS has been described in tropical and sub-tropical regions. However, there is growing evidence of cases detected in developed countries favored by increasing migration and the advance in immunosuppressive therapies for oncologic and inflammatory diseases. SHS is characterized by massive multiplication of larvae, typically in immunocompromised hosts. Clinical manifestations vary according to the organ involved and include diarrhea, intestinal bleeding, alveolar hemorrhages, heart failure, jaundice, bacteremia among others. Despite advances in the understanding of this condition, fatality rates are near 90%. Clinicians should consider SHS in the differential diagnosis of acutely ill patients with multiple organ damage and epidemiological risk factors. Adverse outcomes are common, especially with delayed anti-parasitic treatment.
- 6 February 2019
- Published by Springer Nature in Journal of Parasitic Diseases
- Vol. 43 (2) , 167-175
Strongyloides stercoralis hyperinfection syndrome: a deeper understanding of a neglected disease
Strongyloides stercoralis hyperinfection syndrome (SHS) is a life-threatening condition that warrants early detection and management. We describe the pathogenesis, organ-specific clinical manifestations, and risk factors associated to this condition. A comprehensive review of the literature was conducted in PubMed, LILACS, EBSCO and SciELO by using the keywords: “hyperinfection syndrome”; “Strongyloides stercoralis”; “disseminated strongyloidiasis”; “systemic strongyloidiasis”, “pathogenesis” and “pathophysiology”. Relevant articles on this topic were evaluated and included by consensus. Also, a secondary search of the literature was performed. Articles in English and Spanish language were included. SHS has been described in tropical and sub-tropical regions. However, there is growing evidence of cases detected in developed countries favored by increasing migration and the advance in immunosuppressive therapies for oncologic and inflammatory diseases. SHS is characterized by massive multiplication of larvae, typically in immunocompromised hosts. Clinical manifestations vary according to the organ involved and include diarrhea, intestinal bleeding, alveolar hemorrhages, heart failure, jaundice, bacteremia among others. Despite advances in the understanding of this condition, fatality rates are near 90%. Clinicians should consider SHS in the differential diagnosis of acutely ill patients with multiple organ damage and epidemiological risk factors. Adverse outcomes are common, especially with delayed anti-parasitic treatment.